Facebook
X
LinkedIn
ForwardFrom Knowledge to Action: Reducing the Risk of Congenital CMV
Overview
| Registration |
|---|
If you have questions, please email Kristina Seier. |
Description
Did you know that one in five U.S.-born children with congenital CMV (cCMV) will develop permanent problems such as hearing loss or developmental disabilities?
cCMV is the most common infectious cause of birth defects in the United States, yet awareness among healthcare professionals remains limited. While most infants born with cCMV do not experience long-term health complications, a significant number can develop serious issues such as hearing loss, vision problems, or developmental delays.
This informative panel discussion will provide pediatricians, primary care providers, and other healthcare professionals with a foundational understanding of the CMV virus, including how it is transmitted and why certain pregnancies are at higher risk. Experts will highlight key risk factors, such as maternal primary infection, reinfection, and reactivation, as well as other transmission routes, including blood transfusion and organ transplantation. They will also discuss how to talk with pregnant women about risk factors, transmission, diagnosis, and the next steps.
Learning Objectives
- Discuss the virology and epidemiology of congenital Cytomegalovirus (cCMV).
- List three strategies for early identification and counseling of at-risk pregnant patients.
- Foster collaboration between families, the healthcare team, primary care physicians, and public health advocates to improve education, early detection, and outcomes related to cCMV
Panelists
Patrick Courtney, MD
Family Medicine, Maternity Care, MercyOne
Amanda Devereaux, RN, BSN
Previously with the National CMV Foundation and lived experience as a mother with a child born with cCMV
Joel Waddell, DO
Pediatric Infectious Diseases, UnityPoint Health
CE Credits
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences
(DMU) and the Iowa Medical Society. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. - DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
 |  |
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosures
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Patrick Courtney, MD - Speaker
- Ryan Roberts - Planning Committee Member
- Kristina Seier, LMSW - Activity Director and Planning Committee Member
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.
- Amanda Devereaux, RN, BSN - Speaker
- Consultant: Moderna
- Honoraria: Medscape
- Does intend to discuss an off-label use of a commercial product.
- Joel Waddell, DO - Speaker
- Does not have a financial relationship to disclose, but does intend to discuss an off-label use of a commercial product.
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 1A
- 1.00 CE Contact Hour(s)